Initiation of once daily insulin detemir is not associated with weight gain in patients with type 2 diabetes mellitus: results from an observational study

• Published in: Diabetology and metabolic syndrome Vol. 5; no. 1; p. 56
• Main Authors: Yale, Jean-François, Damci, Taner, Kaiser, Marcel, Karnieli, Eddy, Khunti, Kamlesh, Liebl, Andreas, Baeres, Florian Mm, Svendsen, Anne Louise, Ross, Stuart A
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 02.10.2013; BioMed Central
• Subjects: Body mass index; Complications and side effects; Diabetes; Dosage and administration; Glucose; Glycosylated hemoglobin; Health aspects; Insulin; Insulin detemir; Insulin resistance; Obesity; Pharmaceutical industry; Type 2 diabetes; France; United States; United Kingdom; Canada; Turkey; United Kingdom > UK; China; Poland; Italy; Israel; Portugal; Germany; Spain

Obesity is common in type 2 diabetes (T2DM) and is associated with increased risk of morbidity and all-cause mortality. This analysis describes weight changes associated with insulin detemir initiation in real-life clinical practice. Study of Once-Daily Levemir (SOLVE) was a 24-week international ob...